Molecular Mechanisms for in Vivo Cholesterol-lowering Effect by Lactobacillus plantarum

被引:0
|
作者
Jin D. [1 ]
Ma W. [2 ]
机构
[1] Key Laboratory of Dairy Science, Ministry of Education, Northeast Agricultural University, Harbin
[2] Heilongjiang University of Chinese Medicine, Harbin
关键词
Cholesterol; Lactobacillus plantarum; Mice; Western blot;
D O I
10.16429/j.1009-7848.2020.03.007
中图分类号
学科分类号
摘要
Objective: It was evaluated that the effect and genes related to hepatic cholesterol metabolism of Lactobacillus plantarum KLDS strain on the cholesterol metabolism in hyperlipidemia mice. Method: Health C57BL/6 male mice, as objects, were divided into control group, model group, low-dose group, high-dose group and pravastatin group, which were respectively given normal saline, Lactobacillus plantarum KLDS1.0386 bacteria suspension and pravastatin solution by gavage for 4 consecutive weeks. The serum levels of total cholesterol (TC), triglyceride (TG), low density lipoprotein-cholesterol (LDL-C) and high density lipoprotein-cholesterol (HDL-C) were determined on the 28th day of the experiment. The genes related to hepatic cholesterol metabolism (HMGCR, LDLR, SREBP2, CYP7A1, FXR) were investigated in mice. Results: After 4 weeks administration, compared with mice fed a high-cholesterol diet without lactic acid bacteria supplementation, there was a significant(P<0.05) decrease in TG, the total cholesterol and LDL-C levels in the serum, and the mice fed the KLDS1.0386 diet had significantly (P<0.05) the down-regulation of HMGCR and FXR (P<0.05) and the up-regulation of CYP7A1 (P<0.05). Concluton: Lactobacillus plantarum KLDS1.0386 has probiotic potential as indicated by its hypocholesterolemic effect both in vivo, it could be as the probiotics with cholesterol-lowering activity. © 2020, Editorial Office of Journal of CIFST. All right reserved.
引用
收藏
页码:52 / 57
页数:5
相关论文
共 14 条
  • [1] Anandharaj M., Sivasankari B., Parveen Rani R., Effects of probiotics, prebiotics, and synbiotics on hypercholesterolemia: a review, Chinese Journal of Biology, 2014, pp. 1-7, (2014)
  • [2] Choi S., Lew L., Yeo S., Et al., Probiotics and the BSH-related cholesterol lowering mechanism: a Jekyll and Hyde scenario, Critical Reviews in Biotechnology, 35, 3, pp. 392-401, (2015)
  • [3] Edel A.L., Rodriguez-Leyva D., Maddaford T.G., Et al., Dietary flaxseed independently lowers circulating cholesterol and lowers it beyond the effects of cholesterol-lowering medications alone in patients with peripheral artery disease, The Journal of Nutrition, 145, 4, pp. 749-757, (2015)
  • [4] Barone E., Di Domenico F., Butterfield D.A., Statins more than cholesterol lowering agents in Alzheimer disease: their pleiotropic functions as potential therapeutic targets, Biochemical Pharmacology, 88, 4, pp. 605-616, (2014)
  • [5] Hotel A.C.O.R., Cordoba A., Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria, Prevention, 5, 1, pp. 1-10, (2001)
  • [6] Jeun J., Kim S., Cho S., Et al., Hypocholesterolemic effects of Lactobacillus plantarum KCTC3928 by increased bile acid excretion in C57BL/6 mice, Nutrition, 26, 3, pp. 321-330, (2010)
  • [7] Damodharan K., Palaniyandi S.A., Yang S.H., Et al., Functional probiotic characterization and in vivo cholesterol-lowering activity of Lactobacillus helveticus isolated from fermented cow milk, Journal of Microbiology and Biotechnology, 26, 10, pp. 1675-1686, (2016)
  • [8] Lin C., Tsai C., Lin S., Effects of soy components on blood and liver lipids in rats fed high-cholesterol diets, World Journal of Gastroenterology: WJG, 11, 35, (2005)
  • [9] Fuchs D., Berges C., Opelz G., Et al., HMG-CoA reductase inhibitor simvastatin overcomes bortezomib-induced apoptosis resistance by disrupting a geranylgeranyl pyrophosphate-dependent survival pathway, Biochemical and Biophysical Research Communications, 374, 2, pp. 309-314, (2008)
  • [10] Eberl E.D., Hegarty B., Bossard P., Et al., SREBP transcription factors: master regulators of lipid homeostasis, Biochimie, 86, 11, pp. 839-848, (2004)